Endovia Health Sciences Debt-to-EBITDA Ratio Growth & History (EDVA)

Endovia Health Sciences's debt-to-ebitda ratio was 0.17 for fiscal 2018.

View full Endovia Health Sciences company overview

Endovia Health Sciences annual debt-to-ebitda ratio history

Endovia Health Sciences annual debt-to-ebitda ratio

Fiscal yearPeriod endedDebt-to-EBITDA ratioChangeGrowth
20182018-12-310.17
20162016-12-318.197.59+1284.43%
20152015-12-310.59−166.04−99.65%
20142014-12-31166.63158.20+1877.25%
20132013-12-318.43

Endovia Health Sciences debt-to-ebitda ratio trends

Over the last five fiscal years, Endovia Health Sciences's debt-to-ebitda ratio decreased from 8.43 to 0.17, a change of −8.26. The latest reported quarter, Q4 2018, shows 0.17.

About the metric

What the debt-to-EBITDA ratio means

Debt-to-EBITDA compares interest-bearing debt with operating earnings before interest, taxes, depreciation, and amortization. It is commonly used to assess leverage, but it is generally unsuitable for banks and other financial companies.

Calculation and source

How debt-to-EBITDA is calculated

TickerStat divides period-end total debt by annual EBITDA. Quarterly observations use trailing-12-month EBITDA. Periods with zero or negative EBITDA are excluded because the leverage multiple would not be meaningful. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Endovia Health Sciences source filings ↗

Community posts

It’s quiet here.

No posts about EDVA yet. Start the conversation.

Write the first post